Approach to the diagnosis and treatment of acute subarachnoid hemorrhage in a patient with sickle cell disease.

Am J Emerg Med

Division of Hematology & Oncology, Department of Medicine, University of Florida, Gainesville, FL.

Published: March 2015

We report a case of subarachnoid hemorrhage in a 38-year-old patient with sickle cell anemia. This case highlights the limitations of non contrast computed tomography in the diagnosis of subarachnoid hemorrhage in patients with sickle cell disease as well as the special needs of this patient population in addressing the treatment of stroke.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajem.2014.08.068DOI Listing

Publication Analysis

Top Keywords

subarachnoid hemorrhage
12
sickle cell
12
patient sickle
8
cell disease
8
approach diagnosis
4
diagnosis treatment
4
treatment acute
4
acute subarachnoid
4
hemorrhage patient
4
disease report
4

Similar Publications

In forensic neuropathology, the β-amyloid precursor protein (β-APP) immunostain is used to diagnose axonal injury (AI). The two most common aetiologies are traumatic (TAI) and ischaemic (vascular; VAI). We aimed to identify background characteristics and neuropathology findings that are suggestive of TAI, VAI, or no AI in neuropathologically examined medico-legal autopsy cases.

View Article and Find Full Text PDF

Background: Accurate identification of the risk of postoperative pneumonia (POP) in aneurysmal subarachnoid hemorrhage (aSAH) is essential for the implementation of stratified treatment. This study evaluated the relevance and utility of the Systemic Immuno-inflammatory Index (SII) and the Systemic Inflammatory Response Index (SIRI) in predicting pneumonia after aSAH.

Methods: Two hundred and forty patients undergoing aSAH intervention were included.

View Article and Find Full Text PDF

Background: The effect of targeted temperature management (TTM) combined with decompressive craniectomy (DC) on poor-grade aneurysmal subarachnoid hemorrhage (aSAH) has not been previously addressed in the literature. This study aims to investigate the therapeutic outcomes of the combination of TTM and DC in patients with poor-grade aSAH.

Methods: This study represents a secondary analysis of the Multicenter Clinical Research on Targeted Temperature Management of Poor-grade Aneurysmal Subarachnoid Hemorrhage (High-Quality TTM for PaSAH), a multicenter prospective study conducted in China.

View Article and Find Full Text PDF

Peri-mesencephalic subarachnoid haemorrhage (PMSAH) is considered to be a clinically benign subset of subarachnoid haemorrhage (SAH). Cranial nerve palsies have been previously reported as rare sequelae of PMSAH. Herein, we report an unusual case of multiple cranial nerve palsies as a presenting feature of PMSAH and a review of the literature for cranial nerve palsies post-PMSAH.

View Article and Find Full Text PDF

Introduction: Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is recognized as a diagnostic and prognostic blood biomarker for traumatic brain injury (TBI). This study aimed to evaluate whether UCH-L1 concentrations measured in patients' urine post-injury could serve as a diagnostic or prognostic biomarker for outcomes in various types of acute brain injuries (ABI).

Material And Methods: This pilot study included 46 ABI patients: aneurysmal subarachnoid hemorrhage (n = 22), ischemic stroke (n = 16), and traumatic brain injury (n = 8), along with three healthy controls.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!